Depomed sues Watson over filing of Glumetza ANDA in US
This article was originally published in Scrip
Executive Summary
The US specialty pharmaceutical company DepoMed has filed a patent infringement lawsuit against Watson Pharmaceuticals in the US District Court for the District of Delaware over the generic maker’s bid to market a version of diabetes drug Glumetza (metformin HCl extended release tablets) in a 1,000mg tablet form.